IntelGenx (Seller)SWK Holdings (Buyer)
IntelGenx sells its royalty rights for antidepressant Forfivo XL to SWK Holdings for $6 million
IntelGenx (Licensor)Edgemont (Licensee)
IntelGenx granted Edgemont exclusive rights to commercialize CPI-300 in the U.S.
Set Email Alert